1st Quarter - Report

BROWN RUDNICK LLP for HOSPIRA, INC.

Firm
Client
Income
$30,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report Apr 20, 2009 $30,000 Replaced
1st Quarter - Report (this page) Apr 20, 2009 $30,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 1548 - The Pathway to Biosimilars Act; S. 726 & H.R. 1427 - The Promoting Innovation and Access to Life-Savings Medicine Act; S.301 - Physician Payments Sunshine Act of 2009; H.R. 1346 & S. 540 - Medical Device Safety Act of 2009

LobbyistCovered position, as disclosed
LISA LAYMAN New SPA, Sen Stabenow(05-07)
HENRY W MENN Min SD & Counsel, Cmte on Vet Affairs (04)

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 726 (111th), H.R. 1548 (111th), H.R. 1427 (111th), S. 301 (111th), S. 540 (111th), H.R. 1346 (111th)

Pharmacy PHA

Issues relating to drug pedigree

LobbyistCovered position, as disclosed
LISA LAYMAN SPA, Sen Stabenow(05-07)
HENRY W MENN Min SD & Counsel, Cmte on Vet Affairs (04)

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.